BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 19029628)

  • 1. Emerging roles of nodal and Cripto-1: from embryogenesis to breast cancer progression.
    Strizzi L; Postovit LM; Margaryan NV; Seftor EA; Abbott DE; Seftor RE; Salomon DS; Hendrix MJ
    Breast Dis; 2008; 29():91-103. PubMed ID: 19029628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nodal and Cripto-1: embryonic pattern formation genes involved in mammary gland development and tumorigenesis.
    Kenney NJ; Adkins HB; Sanicola M
    J Mammary Gland Biol Neoplasia; 2004 Apr; 9(2):133-44. PubMed ID: 15300009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cripto-1: a multifunctional modulator during embryogenesis and oncogenesis.
    Strizzi L; Bianco C; Normanno N; Salomon D
    Oncogene; 2005 Aug; 24(37):5731-41. PubMed ID: 16123806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody blockade of the Cripto CFC domain suppresses tumor cell growth in vivo.
    Adkins HB; Bianco C; Schiffer SG; Rayhorn P; Zafari M; Cheung AE; Orozco O; Olson D; De Luca A; Chen LL; Miatkowski K; Benjamin C; Normanno N; Williams KP; Jarpe M; LePage D; Salomon D; Sanicola M
    J Clin Invest; 2003 Aug; 112(4):575-87. PubMed ID: 12925698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cripto localizes Nodal at the limiting membrane of early endosomes.
    Blanchet MH; Le Good JA; Oorschot V; Baflast S; Minchiotti G; Klumperman J; Constam DB
    Sci Signal; 2008 Nov; 1(45):ra13. PubMed ID: 19001664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Cripto-1 during epithelial-to-mesenchymal transition in development and cancer.
    Rangel MC; Karasawa H; Castro NP; Nagaoka T; Salomon DS; Bianco C
    Am J Pathol; 2012 Jun; 180(6):2188-200. PubMed ID: 22542493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cripto-independent Nodal signaling promotes positioning of the A-P axis in the early mouse embryo.
    Liguori GL; Borges AC; D'Andrea D; Liguoro A; Gonçalves L; Salgueiro AM; Persico MG; Belo JA
    Dev Biol; 2008 Mar; 315(2):280-9. PubMed ID: 18241853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of extra-embryonic endoderm stem cell differentiation by Nodal and Cripto signaling.
    Kruithof-de Julio M; Alvarez MJ; Galli A; Chu J; Price SM; Califano A; Shen MM
    Development; 2011 Sep; 138(18):3885-95. PubMed ID: 21862554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-cell-autonomous role for Cripto in axial midline formation during vertebrate embryogenesis.
    Chu J; Ding J; Jeays-Ward K; Price SM; Placzek M; Shen MM
    Development; 2005 Dec; 132(24):5539-51. PubMed ID: 16291788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The threonine that carries fucose, but not fucose, is required for Cripto to facilitate Nodal signaling.
    Shi S; Ge C; Luo Y; Hou X; Haltiwanger RS; Stanley P
    J Biol Chem; 2007 Jul; 282(28):20133-41. PubMed ID: 17504756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cripto-1 activates nodal- and ALK4-dependent and -independent signaling pathways in mammary epithelial Cells.
    Bianco C; Adkins HB; Wechselberger C; Seno M; Normanno N; De Luca A; Sun Y; Khan N; Kenney N; Ebert A; Williams KP; Sanicola M; Salomon DS
    Mol Cell Biol; 2002 Apr; 22(8):2586-97. PubMed ID: 11909953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the cripto (EGF-CFC) family in embryogenesis and cancer.
    Bianco C; Normanno N; Salomon DS; Ciardiello F
    Growth Factors; 2004 Sep; 22(3):133-9. PubMed ID: 15518236
    [No Abstract]   [Full Text] [Related]  

  • 13. Dual roles of Cripto as a ligand and coreceptor in the nodal signaling pathway.
    Yan YT; Liu JJ; Luo Y; E C; Haltiwanger RS; Abate-Shen C; Shen MM
    Mol Cell Biol; 2002 Jul; 22(13):4439-49. PubMed ID: 12052855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Cripto-1 in stem cell maintenance and malignant progression.
    Bianco C; Rangel MC; Castro NP; Nagaoka T; Rollman K; Gonzales M; Salomon DS
    Am J Pathol; 2010 Aug; 177(2):532-40. PubMed ID: 20616345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Nodal and Cripto-1: Perspectives Inside Dual Potential Theranostic Cancer Biomarkers.
    Sandomenico A; Ruvo M
    Curr Med Chem; 2019; 26(11):1994-2050. PubMed ID: 30207211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cripto is a noncompetitive activin antagonist that forms analogous signaling complexes with activin and nodal.
    Kelber JA; Shani G; Booker EC; Vale WW; Gray PC
    J Biol Chem; 2008 Feb; 283(8):4490-500. PubMed ID: 18089557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cripto binds transforming growth factor beta (TGF-beta) and inhibits TGF-beta signaling.
    Gray PC; Shani G; Aung K; Kelber J; Vale W
    Mol Cell Biol; 2006 Dec; 26(24):9268-78. PubMed ID: 17030617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cripto-1: an embryonic gene that promotes tumorigenesis.
    de Castro NP; Rangel MC; Nagaoka T; Salomon DS; Bianco C
    Future Oncol; 2010 Jul; 6(7):1127-42. PubMed ID: 20624125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential immunohistochemical detection of transforming growth factor alpha, amphiregulin and CRIPTO in human normal and malignant breast tissues.
    Panico L; D'Antonio A; Salvatore G; Mezza E; Tortora G; De Laurentiis M; De Placido S; Giordano T; Merino M; Salomon DS; Mullick WJ; Pettinato G; Schnitt SJ; Bianco AR; Ciardiello F
    Int J Cancer; 1996 Jan; 65(1):51-6. PubMed ID: 8543395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nodal signaling uses activin and transforming growth factor-beta receptor-regulated Smads.
    Kumar A; Novoselov V; Celeste AJ; Wolfman NM; ten Dijke P; Kuehn MR
    J Biol Chem; 2001 Jan; 276(1):656-61. PubMed ID: 11024047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.